
### [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842)
**Label:** Indolent B-cell non-Hodgkin lymphoma

**Subclasses:** [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038) (B-cell chronic lymphocytic leukemia), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226) (Waldenstr√∂m macroglobulinemia), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545) (Follicular lymphoma), 

**Corr. equiv. classes:** [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:610430](http://purl.obolibrary.org/obo/OMIM_610430), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 35.87%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 30.81%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 29.83%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 29.58%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 28.70%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 28.29%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 26.42%
- Thing 26.42%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 26.42%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 23.79%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 21.65%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 19.71%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 14.38%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 13.82%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 13.79%


